These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16210624)

  • 1. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin.
    Grdic D; Ekman L; Schön K; Lindgren K; Mattsson J; Magnusson KE; Ricciardi-Castagnoli P; Lycke N
    J Immunol; 2005 Oct; 175(8):5192-202. PubMed ID: 16210624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
    Eriksson K; Fredriksson M; Nordström I; Holmgren J
    Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and tolerance.
    Lycke N
    Immunol Lett; 2005 Mar; 97(2):193-8. PubMed ID: 15752558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
    Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
    Front Immunol; 2018; 9():2212. PubMed ID: 30319653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
    Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.
    Wikstrom ME; Batanero E; Smith M; Thomas JA; von Garnier C; Holt PG; Stumbles PA
    J Immunol; 2006 Jul; 177(2):913-24. PubMed ID: 16818746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation.
    Kawamura YI; Kawashima R; Shirai Y; Kato R; Hamabata T; Yamamoto M; Furukawa K; Fujihashi K; McGhee JR; Hayashi H; Dohi T
    Eur J Immunol; 2003 Nov; 33(11):3205-12. PubMed ID: 14579289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.
    Lavelle EC; McNeela E; Armstrong ME; Leavy O; Higgins SC; Mills KH
    J Immunol; 2003 Sep; 171(5):2384-92. PubMed ID: 12928385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
    Sun JB; Flach CF; Czerkinsky C; Holmgren J
    J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue.
    Reis e Sousa C; Germain RN
    J Immunol; 1999 Jun; 162(11):6552-61. PubMed ID: 10352271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
    Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
    J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity.
    Gustafsson T; Hua YJ; Dahlgren MW; Livingston M; Johansson-Lindbom B; Yrlid U
    Eur J Immunol; 2013 Jul; 43(7):1779-88. PubMed ID: 23649516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
    Wakabayashi A; Shimizu M; Shinya E; Takahashi H
    Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
    Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
    J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells.
    Hou W; Wu Y; Sun S; Shi M; Sun Y; Yang C; Pei G; Gu Y; Zhong C; Sun B
    J Immunol; 2003 Feb; 170(4):1728-36. PubMed ID: 12574336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
    Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
    J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.